Tandem Diabetes Care

Insulin delivery and diabetes technology company.

Based in CA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $220K in lobbying spend across 6 quarterly filings, Tandem Diabetes Care is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2024 to 2025.

$220K
Total Spend
2
Years Active
1
Firms Hired
4
Lobbyists Deployed
3
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2024$20K
2025$200K

Issues Lobbied

Medicare/MedicaidHealth IssuesBudget/Appropriations

Lobbying Firms

The Nickles Group, LLC

Lobbyists

Brett BakerGreg D'angeloMary Savary TaylorNicole Wright

Government Agencies Targeted

These are the government entities that Tandem Diabetes Care disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATECenters For Medicare and Medicaid Services (CMS)Health & Human Services, Dept of (HHS)Office of Management & Budget (OMB)
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues, Budget/Appropriations

Issues related to coverage and access to diabetes care and technologies.

Issues related to Medicare coverage of insulin pumps.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

Kaiser Foundation Health Plan INC
$31.5M total spend
Biomarin Pharmaceutical INC.
$9.6M total spend
Acadia Pharmaceuticals
$7.3M total spend
Sarepta Therapeutics, INC.
$6.3M total spend
Teladoc Health, INC.
$2.5M total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.